Latin America Breast Cancer Genetics and Risk Modeling
Official title: Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
Funded at University of California at Davis · NIH-11535298 · Data updated 2026-11-12
A large study of diverse Latin American women aims to improve how we predict breast cancer risk using genetic information.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $6,480 |
| NIH project number | 3R01CA286650-03S5 |
| Project ID | NIH-11535298 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are women at risk for breast cancer or with a family history who identify as Latin American or Hispanic/Latina and who have or may contribute genetic data.
✕Less likely to help
Individuals without or outside the target ancestry group or with no plan to participate in genetic-related data collection may not benefit.
What this research studies
This project brings together data from thousands of women across Latin America and the U.S. diaspora to understand how ancestry and geography affect breast cancer risk. Researchers will combine existing studies to build more accurate risk scores that reflect ancestry diversity. The study will use germline genetic data and existing risk factors to create predictive models that can guide personalized screening for women who may be at higher risk.
Why it matters
Potential benefit: If successful, this work could lead to more accurate, personalized breast cancer risk assessments for diverse populations.
How similar studies have gone: Previous diverse-ancestry GWAS have improved risk prediction, and this larger, multi-country effort aims to enhance accuracy further.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Fejerman, Laura — University of California at Davis
- Study coordinator: Fejerman, Laura
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.